The diagnostic value of immunohistochemically detected methylthioadenosine phosphorylase deficiency in malignant pleural mesotheliomas.
Zimling, Zarah Glad; Jørgensen, Anne; Santoni-Rugiu, Eric.
; 60(6B): E96-105, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22394205
Prognostication and monitoring of mesothelioma using biomarkers: a systematic review.
Development and validation of a 2nd tier test for identification of purine nucleoside phosphorylase deficiency patients during expanded newborn screening by liquid chromatography-tandem mass spectrometry.
Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry.
Biomarkers and prognostic factors for malignant pleural mesothelioma.
Inverse enzyme isotope effects in human purine nucleoside phosphorylase with heavy asparagine labels.
Catalytic site cooperativity in dimeric methylthioadenosine nucleosidase.
[Detection of p16 by fluorescence in-situ hybridization and immunohistochemistry in malignant mesothelioma].
Markers for the non-invasive diagnosis of mesothelioma: a systematic review.
Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma.
Modulating Enzyme Catalysis through Mutations Designed to Alter Rapid Protein Dynamics.